Filing Details
IRIDEX CORP (NASDAQ:IRIX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 18, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:IRIX
IRIDEX CORP (IRIX) Files Quarterly Report for Q0
IRIDEX CORP (NASDAQ:IRIX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 18, 2026.
At publication ·
What changed
IRIDEX CORP (NASDAQ:IRIX) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- IRIDEX CORP filed its quarterly report (Form 10-Q) with the SEC on August 18, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $0.93 per share with a market capitalization of $16.7 million.
- The 10-Q filing includes timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
IRIDEX CORP's stock currently trades at $0.93 with a market capitalization of $16.7M.
The 10-Q provides IRIDEX CORP's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for IRIDEX CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IRIX Stock Page
Frequently Asked Questions
Where can I read IRIX's SEC filings?
Browse all filings on our IRIX SEC filings page.
What types of SEC filings does IRIDEX CORP file?
Public companies like IRIDEX CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.